Daiichi Sankyo unveils APAC regional hub for RDPV QA operations in Singapore

Daiichi Sankyo, an innovative global healthcare company, has launched its subsidiary Daiichi Sankyo Singapore ...

February 22, 2024 | Thursday | Company results
Singapore approves AffaMed Therapeutics drug for Ocular Inflammation

China's AffaMed Therapeutics, has obtained New Drug Application (NDA) from Singapore Health Sciences Authority (HSA...

February 21, 2024 | Wednesday | News
Australian govt injects $50 M to construct world-leading artificial heart

The Australian government is providing $50 million to develop and commercialise the world’s most advanced artifici...

February 20, 2024 | Tuesday | News
Japan's Astellas Pharma inks oncology deal worth $800 M with US-based biotech startup Kelonia

Japan headquartered Astellas Pharma and US-based biotech startup Kelonia Therapeutics have announced a collaborative eff...

February 20, 2024 | Tuesday | News
China develops potential new treatment for brain tumours and Parkinson’s disease

A joint multi-disciplinary team from The Chinese University of Hong Kong (CUHK)’s Faculty of Medicine (CU Medicine...

February 15, 2024 | Thursday | News
Latest insights on genetic testing related hearing loss

According to the World Health Organization (WHO), approximately 2.5 billion people worldwide are estimated to have some ...

February 9, 2024 | Friday | Analysis
Korean startup C-Biomex announces oncology research partnership with US-based MD Anderson

The University of Texas MD Anderson Cancer Center in the US, and South Korea-based startup C-Biomex have announced ...

February 12, 2024 | Monday | News
Australia's Recce partners Indonesia's Etana Biotech to advance anti-infective R&D, manufacturing 

Recce Pharmaceuticals Limited, the Company developing a New Class of Synthetic Anti-Infectives, has signed Memorand...

February 8, 2024 | Thursday | News
Harnessing AI’s Potential for a Revolution in Cancer Screening

Imagine a world where a non-invasive breast cancer test delivers results within 15 minutes, costing less than half the p...

February 7, 2024 | Wednesday | Analysis
Empowering Lives: Rare Disease Diagnostics and Awareness

Rare diseases, often overlooked, affect a significant portion of the global population. However, early detection and int...

February 7, 2024 | Wednesday | Analysis
Sysmex and Hitachi High-Tech to collaboratively develop New Genetic Testing Systems

Sysmex Corporation and Hitachi High-Tech Corporation are collaborating to develop novel genetic testing systems based on...

February 8, 2024 | Thursday | News
AstraZeneca expands US manufacturing footprint to accelerate next-gen cell therapy development

AstraZeneca is investing $300 million in a state-of-the-art facility in Rockville, MD to launch its life-saving cell the...

February 7, 2024 | Wednesday | News
Australian government invests $20 M to find new therapies for childhood brain cancers

The Australian government is funding a wide-ranging national research programme that will give new hope and help to Aust...

February 5, 2024 | Monday | News
Singapore develops new and precise way to treat most common type of brain cancer

Researchers led by Nanyang Technological University, Singapore (NTU Singapore) have developed a new and precise way to t...

February 2, 2024 | Friday | News
Experts advocate HPV Vaccination Programmes for Gynaecologic Cancer prevention in MENA region

The 16th Obstetrics and Gynaecology Conference took place on 30 January under the theme ‘From evidence to practice...

January 30, 2024 | Tuesday | Opinion
Breakthroughs in Rare Diseases Therapeutics

The previous year witnessed many promising developments in the fight against rare diseases. The recent Casgevy’s F...

February 1, 2024 | Thursday | Analysis
Trailblazing Impact of Antibody-Drug Conjugates

The field of Antibody-Drug Conjugates (ADCs) has experienced a remarkable transformation, shifting from dormancy to a su...

February 1, 2024 | Thursday | Opinion
Next-Gen ADCs as Precision Weapon Against Cancer

Cancer poses a significant challenge for the pharmaceutical industry, driving a constant search for improved oncology dr...

February 1, 2024 | Thursday | Analysis

Podcast

Survey Box

× Please select an option to participate in the poll.
Processing...   View poll results   More polls

× You have successfully cast your vote.
{{ optionDetail.option }}{{ optionDetail.percentage }}%
{{ optionDetail.percentage }}% Complete
More polls